Cargando…

Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting

The Asian-Indian phenotype of type 2 diabetes mellitus is uniquely characterized for cardio-metabolic risk. In the context of implementing patient-centric holistic cardio-metabolic risk management as a priority, the choice of various combinations of antidiabetic agents should be individualized. Comb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chadha, Manoj, Das, Ashok Kumar, Deb, Prasun, Gangopadhyay, Kalyan Kumar, Joshi, Shashank, Kesavadev, Jothydev, Kovil, Rajiv, Kumar, Surender, Misra, Anoop, Mohan, Viswanathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Practical Approach
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948458/ https://www.ncbi.nlm.nih.gov/pubmed/35334083 http://dx.doi.org/10.1007/s13300-022-01219-x

Ejemplares similares

Capacity and confidence building for general practitioners on optimum insulin use
por: Kalra, Sanjay, et al.
Publicado: (2019)

Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective
por: Mohan, Viswanathan, et al.
Publicado: (2023)

Evidence-Based Consensus on Positioning of SGLT2i in Type 2 Diabetes Mellitus in Indians
por: Singh, Awadhesh Kumar, et al.
Publicado: (2019)

Sodium-glucose Cotransporter-2 Inhibitors in Combination with Other Glucose-lowering Agents for the Treatment of Type 2 Diabetes Mellitus
por: Kalra, Sanjay, et al.
Publicado: (2018)

Relook at DPP-4 inhibitors in the era of SGLT-2 inhibitors
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Suggested use of vaccines in diabetes
por: Kesavadev, Jothydev, et al.
Publicado: (2012)

Reducing the Cost of Diabetes Care with Telemedicine, Smartphone, and Home Monitoring
por: Kesavadev, Jothydev, et al.
Publicado: (2023)

FRAILTY AND THE COMPARATIVE EFFECTIVENESS AND SAFETY OF SGLT2I AND DPP4I IN OLDER ADULTS WITH TYPE 2 DIABETES
por: Kim, Dae H, et al.
Publicado: (2019)

Digital health and diabetes: experience from India
por: Kesavadev, Jothydev, et al.
Publicado: (2021)

Periodic Fever: A Review on Clinical, Management and Guideline for Iranian Patients - Part I
por: Ahmadinejad, Zahra, et al.
Publicado: (2014)

Patients’ Preference Between DPP4i and SGLT2i for Type 2 Diabetes Treatment: A Cross-Sectional Evaluation
por: Costa Gil, José Esteban, et al.
Publicado: (2022)

Steroid use during COVID-19 infection and hyperglycemia – What a physician should know
por: Sosale, Aravind, et al.
Publicado: (2021)

Expert Opinion: A Call for Basal Insulin Titration in Patients with Type 2 Diabetes in Daily Practice: Southeast European Perspective
por: Hancu, Nicolae, et al.
Publicado: (2021)

Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization
por: Kesavadev, Jothydev, et al.
Publicado: (2021)

Expert Opinion on the Therapeutic Use of the Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide: a Central/Eastern European Perspective
por: Haluzík, Martin, et al.
Publicado: (2020)

Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Gan, Sushrima, et al.
Publicado: (2020)

311 Rib Fractures in Geriatric Trauma: A Review of 1,037 Cases at a Single Level I Trauma Center
por: Sheppard, Forest, et al.
Publicado: (2022)

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Trivandrum cohort of the A(1)chieve study
por: Kesavadev, Jothydev
Publicado: (2013)

Health care utilization and costs associated with switching from DPP-4i to GLP-1RA or SGLT2i: an observational cohort study
por: Newman, Terri Victoria, et al.
Publicado: (2021)

Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel
por: Chawla, Manoj, et al.
Publicado: (2020)

Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes
por: Gomez-Peralta, Fernando, et al.
Publicado: (2017)

371 Decreased Contraction Rate, Altered Calcium Transients, and Increased Proliferation seen in Patient-specific iPSC-CMs Modeling Ebsteins Anomaly and Left Ventricular Noncompaction
por: Samudrala, Sai Suma, et al.
Publicado: (2022)

Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians
por: Buckley, Megan C., et al.
Publicado: (2021)

435 Age-dependent Regulation of Follicle-Stimulating Hormone N-glycosylation in Female Gonadotrope Cells
por: McDonald, Rosemary, et al.
Publicado: (2022)

Liraglutide therapy beyond glycemic control: an observational study in Indian patients with type 2 diabetes in real world setting
por: Kesavadev, Jothydev, et al.
Publicado: (2012)

Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
por: Kesavadev, Jothydev, et al.
Publicado: (2015)

Unproven Therapies for Diabetes and Their Implications
por: Kesavadev, Jothydev, et al.
Publicado: (2016)

Clinical Evidence and Practice-Based Guidelines on the Utility of Basal Insulin Combined Oral Therapy (Metformin and Glimepiride) in the Current Era
por: Shrivastava, Abhishek, et al.
Publicado: (2023)

“Does having diabetes increase chances of contracting COVID-19 infection?”
por: Gangopadhyay, Kalyan Kumar
Publicado: (2020)

318 Building A Better CAR: Improving CAR-T Trafficking in Cancer Therapy
por: Hong, Yeonsun, et al.
Publicado: (2022)

Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)
por: Kesavadev, Jothydev, et al.
Publicado: (2017)

Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System
por: Kesavadev, Jothydev, et al.
Publicado: (2023)

Response to Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948–1957
por: Gan, Sushrima, et al.
Publicado: (2020)

The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system
por: Schernthaner, Guntram, et al.
Publicado: (2014)

Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors
por: Scheen, André J.
Publicado: (2018)

Impacts of the DPP-4 Inhibitor Saxagliptin and SGLT-2 Inhibitor Dapagliflozin on the Gonads of Diabetic Mice
por: Alshamrani, Ali A., et al.
Publicado: (2023)

Modern basal insulin analogs: An incomplete story
por: Singh, Awadhesh Kumar, et al.
Publicado: (2014)

Human Digital Twin for Personalized Elderly Type 2 Diabetes Management
por: Thamotharan, Padmapritha, et al.
Publicado: (2023)

SGLT2i: beyond the glucose-lowering effect
por: Ni, Lihua, et al.
Publicado: (2020)

Mineral and Electrolyte Disorders With SGLT2i Therapy
por: Cianciolo, Giuseppe, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6qv6r9akiasia8ihsl5suq5p44